Comparsion of 2% Tanacetum Parthenium Gel with 1% Diclofenac Gel on the pain of patients with primary knee osteoarthritis
Not Applicable
Recruiting
- Conditions
- Osteoartritis.Arthrosis, unspecified
- Registration Number
- IRCT2017092710222N14
- Lead Sponsor
- Vice chancellor for research of Shahrekord University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
45_75 years old; a definitive diagnosis of osteoarthritis disease with specialist
Exclusion criteria: severe diseases such as metabolic disorders and digestive at the same time; severe infection; sensitivity to Tanacetum Parthenium extract; pregnancy; lactation; impaired liver function tests; history of fracture or knee surgery; rheumatoid arthritis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical function. Timepoint: Baseline and Six weeks after intervention. Method of measurement: WOMAC questionnaire.
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: Baseline and six weeks after intervention. Method of measurement: WOMAC questionnaire.